Elevated neutrophil-related immune-inflammatory biomarkers in acute anterior choroidal artery territory infarction

Ning Zhao1, Jia Li1, Qiu-Xia Zhang1

  • 1Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin 300052, China.

Insights

Neutrophil to high-density lipoprotein cholesterol ratio (NHR) and neutrophil to lymphocyte ratio (NLR) can predict early progression in acute anterior choroidal artery infarction. Combining NHR and NLR may offer a better prognostic marker for this condition.

Area of Science:

  • Neurology
  • Biomarkers
  • Stroke Research

Background:

  • Anterior choroidal artery (AChA) territory infarction is associated with rapid progression and poor functional outcomes.
  • Identifying early predictive biomarkers for AChA infarction progression is crucial for timely intervention.

Purpose of the Study:

  • To identify fast and convenient biomarkers for forecasting the early progression of acute AChA infarction.
  • To evaluate the discriminant efficacy of various laboratory indices in predicting AChA infarction progression.

Main Methods:

  • A cohort of 51 acute AChA infarction patients was analyzed.
  • Laboratory indices were compared between early progressive and non-progressive groups.
  • Receiver-operating characteristic (ROC) curve analysis was employed to assess predictive accuracy.

Main Results:

  • Neutrophil to high-density lipoprotein cholesterol ratio (NHR) and neutrophil to lymphocyte ratio (NLR) were significantly higher in progressive AChA infarction.
  • ROC analysis indicated that NHR and NLR, individually and combined, showed discriminant efficacy in predicting progression.
  • The combined NHR and NLR demonstrated a promising area under the ROC curve of 0.751.

Conclusions:

  • NHR and NLR may serve as significant predictors for early progressive acute AChA infarction.
  • The combination of NHR and NLR could be a valuable prognostic marker for patients with an early progressive course of AChA infarction.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
211
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
129
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
15